Last year, the American Academy of Ophthalmology recommended that patients experiencing vision problems while taking semaglutide stop using the drug and consult a physician.
Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged ...
Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...
As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party telehealth prescribers to get their hands on these medications, a new sur | ...
A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
The government-funded study was small and experts say it's not yet clear how safe these drugs are for people who don't need ...
Hims & Hers hit the bullseye with its Super Bowl ad—it sparked a lot of attention from consumers. | Hims & Hers hit the ...
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results